Identification of biomarkers and drug repurposing candidates based on an immune-, inflammation- and membranous glomerulonephritis-associated triplets network for membranous glomerulonephritis | BMC Medical Genomics | Full Text

Identification of biomarkers and drug repurposing candidates based on an immune-, inflammation- and membranous glomerulonephritis-associated triplets network for membranous glomerulonephritis | BMC Medical Genomics | Full Text

Identification of biomarkers and drug repurposing candidates based on an immune-, inflammation- and membranous glomerulonephritis-associated triplets network for membranous glomerulonephritis

Membranous glomerulonephritis (MGN) is a common kidney disease. Despite many evidences support that many immune and inflammation-related genes could serve as effective biomarkers and treatment targets for MGN ...

Authors:Chengwei Zhang, Lei Leng, Zhaozheng Li, Yao Zhao and Jundong Jiao

Citation:BMC Medical Genomics 2020 13:5

Content type:Research article

Published on: 7 January 2020

• ViewFull Text
 
• ViewPDF